Literature DB >> 2421494

[Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis--results of a prospective clinical study].

M Büchler, P Malfertheiner, C Schoetensack, W Uhl, W Scherbaum, H G Beger.   

Abstract

For a period of 14 days we carried out measurements for alpha-1-protease inhibitor, alpha-2-macroglobulin, complement C 3, complement C 4, and C-reactive protein in two different groups of patients with acute pancreatitis. Group I consisted of 13 patients with edematous-interstitial pancreatitis and group II of 22 patients with necrotizing pancreatitis. Diagnosis of acute pancreatitis was established by clinical signs and symptoms, by specific pancreatic enzymes determined in the serum, by imaging procedures, and by laparotomy in 24 cases. The overall detection rate for pancreatic necrosis was 90% for the contrast enhanced CT and 33% for ultrasonography respectively. There were significant differences as to all measured serum parameters between the two morphologically defined pancreatitis groups. The necrosis detection rate was 95% for CRP and 85% for alpha-2-macroglobulin. The combined determination of CRP and alpha-2-macroglobulin is recommended in patients with acute pancreatitis to stage the severity of the disease and to probably replace the CT investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421494

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  10 in total

1.  Serum ribonuclease activity in the diagnosis of pancreatic disease.

Authors:  T P Kemmer; P Malfertheiner; M Büchler; M L Kemmer; H Ditschuneit
Journal:  Int J Pancreatol       Date:  1991-01

2.  Pancreatic Society of Great Britain and Ireland. 12th annual meeting. 6 November, 1987. Abstracts.

Authors: 
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

3.  Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein, alpha 1-antitrypsin, and protease inhibitor alpha 2-macroglobulin.

Authors:  V Gross; J Schölmerich; H G Leser; R Salm; M Lausen; K Rückauer; U Schöffel; L Lay; A Heinisch; E H Farthmann
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

Review 4.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

5.  Scintigraphic assessment of leukocyte infiltration in acute pancreatitis using technetium-99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; C Schümichen; M Lausen; V Gross; H G Leser; L Lay; E H Farthmann; W Gerok
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

6.  Prognostic markers in acute pancreatitis: can pancreatic necrosis be predicted?

Authors:  T Leese; D Shaw; M Holliday
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

Review 7.  Risk Stratification and Early Conservative Treatment of Acute Pancreatitis.

Authors:  Michał Żorniak; Georg Beyer; Julia Mayerle
Journal:  Visc Med       Date:  2019-03-25

8.  Comparison of Ranson, Glasgow, MOSS, SIRS, BISAP, APACHE-II, CTSI Scores, IL-6, CRP, and Procalcitonin in Predicting Severity, Organ Failure, Pancreatic Necrosis, and Mortality in Acute Pancreatitis.

Authors:  Ajay K Khanna; Susanta Meher; Shashi Prakash; Satyendra Kumar Tiwary; Usha Singh; Arvind Srivastava; V K Dixit
Journal:  HPB Surg       Date:  2013-09-24

Review 9.  Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.

Authors:  Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

10.  Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis.

Authors:  Amit Kumar Dutta; Ashish Goel; Richard Kirubakaran; Ashok Chacko; Prathap Tharyan
Journal:  Cochrane Database Syst Rev       Date:  2020-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.